Atlas Trials

The Covid-19 Outpatient Symptom Montelukast Oximetry Trial

Clinical trial NCT04389411 · UNKNOWN

Trial details

NCT number
NCT04389411
Sponsor
McGill University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2022-11-01
Primary completion
2023-01-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.